Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
A new generation of “theranostic” nanoparticles has been shown to both detect and reduce plaques in the arteries. Nanoparticles absorbed by immune cells in the arteries, where they work to lower ...
Former Manhattan chiropractor Clark Petersen began his testimony Friday afternoon in Riley County District Court, in a trial that charges him with numerous counts of sex crimes against 19 women who ...
Typical sites for measurement of core temperature include the pulmonary artery and midesophagus, however, these sites are available in a small minority of patients. In lieu of a direct measurement of ...
The FDA has granted a groundbreaking approval to Humacyte for its off-the-shelf, bioengineered blood vessel implant, designed to replace a patient’s damaged artery following traumatic injuries to the ...
Patients receiving standard treatment for chronic subdural hematoma have a high risk of treatment failure. The effect of adjunctive middle meningeal artery embolization on the risk of treatment ...
TCT 472: A 4-Year Analysis of the National Readmissions Database to Determine Predictors for 90-Day Readmissions for Impella Support Receive the the latest news, research, and presentations from major ...
Popliteal artery entrapment syndrome (PAES) is a rare condition affecting the artery in the back of the knee. It causes pain in the lower legs during exercise. The popliteal artery runs behind the ...
bilibili announced service for Artery Gear: Fusion will end in November 2024 for both the Global and Japanese clients. Released in 2021, the mobile game ran for nearly three years in Japan. A Global ...
The brachial artery is the chief artery supplying blood to the arm, forearm, and hand. It supplies the tissues of the upper limb with oxygen and nutrients. Two terminal brachial artery branches, the ...
The Food and Drug Administration has approved a topical anticholinergic, sofpironium topical gel, 12.45%, for the treatment of primary axillary hyperhidrosis in adults and children aged ≥ 9 years.
Sofpironium bromide indirectly reduces the rate of sweating by preventing the stimulation of acetylcholine receptors that are located on sweat glands. The Food and Drug Administration (FDA) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results